Support PenkeTreace Medical Concepts Inc - Trending symbols
Latest News of Treace Medical Concepts Inc
| Date | Title | Read |
|---|---|---|
| 2025-05-07 02:06 | Treace Medical Concepts, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses. June 10, 2025 Deadline to file Lead Plaintiff Motion. | Read |
| 2025-05-06 19:45 | Deadline Alert: Treace Medical Concepts, Inc. (TMCI) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit | Read |
| 2025-05-05 20:44 | ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI | Read |
| 2025-05-05 19:32 | Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 10, 2025 – TMCI | Read |
| 2025-05-02 20:06 | TMCI LAWSUIT ALERT: Levi & Korsinsky Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline | Read |
| 2025-05-02 00:01 | Treace Medical Concepts, Inc. Investors: Please contact the Portnoy Law Firm to recover your losses; June 10, 2025 Deadline to file Lead Plaintiff Motion | Read |
| 2025-04-29 17:08 | TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP | Read |
| 2025-04-29 16:20 | INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical Concepts, Inc. - TMCI | Read |
| 2025-04-28 18:33 | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of June 10, 2025 in Treace Medical Concepts, Inc. Lawsuit – TMCI | Read |
| 2025-04-28 15:15 | TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Treace Medical Concepts, Inc. Investors of Upcoming Deadline | Read |
Trends
| 2023-12-31 | 2024-03-31 | 2024-06-30 | 2024-09-30 | 2024-12-31 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| EBIT | -4,977 | -12,382 | -17,359 | -2,535 | -19,894 | 5,847 | -14,047 | 14,860 | 813 | |
| EBITDA | -3,208 | -12,242 | -15,450 | -2,328 | -17,778 | 5,888 | -11,890 | 14,940 | 3,050 | |
| Net Interest Income | 274 | 131 | 405 | -187 | 218 | -154 | 64 | -310 | -246 | |
| Total Other Income Expense Net | 297 | 204 | 501 | -209 | 292 | -116 | 176 | -402 | -226 | |
| Accumulated Other Comprehensive Income | -27 | -29 | -56 | -163 | -219 | 71 | -148 | 311 | 163 | |
| Interest Expense | 1,190 | 121 | 1,311 | -26 | 1,285 | -3 | 1,282 | -2,578 | -1,296 | |
| Net non Operating Income Other | -940 | -4,361 | -5,301 | 4,486 | -815 | -127 | -942 | 1,235 | 293 | |
| Net Debt | -76,468 | 22,654 | -53,814 | 23,037 | -30,777 | 14,223 | -16,554 | 65,670 | 49,116 | |
| Income Tax Expense | 1,028 | -88 | 940 | 3,120 | 4,060 | -3,245 | 815 | -1,732 | -917 |
Comments
How you think about this?